Vassall, Anna

Scientific advances and the end of tuberculosis: a report from the Lancet Commission on Tuberculosis

Reid, M., Agbassi, Y. J. P., Arinaminpathy, N., Bercasio, A., Bhargava, A., Bhargava, M., Bloom, A., Cattamanchi, A., Chaisson, R., Chin, D., et al. (2023) · The Lancet

Tuberculosis Research and EpidemiologyInfectious Diseases and Tuberculosis

Cited by 87

Digital adherence technologies to improve tuberculosis treatment outcomes in China: a cluster-randomised superiority trial

Liu, X., Thompson, J., Dong, H., Sweeney, S., Li, X., Yuan, Y., Wang, X., He, W., Thomas, B., Xu, C., et al. (2023) · The Lancet Global Health

Tuberculosis Research and EpidemiologyMedication Adherence and Compliance

Cited by 69

Incorporating Demand and Supply Constraints into Economic Evaluations in Low‐Income and Middle‐Income Countries

Vassall, A., Mangham‐Jefferies, L., Gomez, G. B., Pitt, C., & Foster, N. (2016) · Health Economics

Health Systems, Economic Evaluations, Quality of LifePharmaceutical Economics and Policy

Cited by 52

Superspreading, overdispersion and their implications in the SARS-CoV-2 (COVID-19) pandemic: a systematic review and meta-analysis of the literature

Wegehaupt, O., Endo, A., & Vassall, A. (2023) · BMC Public Health

COVID-19 epidemiological studiesSARS-CoV-2 and COVID-19 Research

Cited by 45

Innovation in evaluating the impact of Integrated Service-Delivery: the Integra indexes of HIV and Reproductive Health integration

Mayhew, S. H., Ploubidis, G. B., Sloggett, A., Church, K., Obure, C. D., Birdthistle, I., Sweeney, S., Warren, C. E., Watts, C., Vassall, A., et al. (2016) · PLoS ONE

Health Policy Implementation ScienceHIV/AIDS Research and Interventions

Cited by 34